Patient safety monitoring in international laboratories (PSMILE)
Active Definitive Contract Awarded
- Contract number
- 75N93027C00001
- Awardee
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,457,291
Award facts
- Opportunity
-
- PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (pSMILE) Pre-Solicitation · 75N93025R00011 · Posted Apr 22, 2025
- Contract value 10% obligated
-
- $3,457,291.00 Current, with exercised options
- $33,754,014.00 Potential, with all options
- Completion date 0% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21218, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a $33.75 million ceiling-value, cost-no-fee definitive contract to The Johns Hopkins University for the Patient Safety Monitoring in International Laboratories (PSMILE) effort on November 10, 2026, with no set-aside used. The prime holds no small business certifications. Place of performance is Baltimore, Maryland.
The contract supports laboratories performing study-specified tests under good clinical laboratory practices in non-U.S. HIV/AIDS clinical trial settings. The pre-solicitation described approximately 150 supported laboratories across 18 countries, a requirement of 13.70 full-time equivalents per year, and authority to add up to 15 laboratories during option periods. The pre-solicitation, posted April 22, 2025, set a May 7, 2025 due date for five-page capability statements from small businesses, and it identified Johns Hopkins as the incumbent holder. Period of performance is a one-year base with six one-year options, for a seven-year maximum, and the source lists an ultimate completion date of November 14, 2033. The pre-solicitation anticipated a start around September 15, 2026.
Quick answers
Who was awarded contract 75N93027C00001?
75N93027C00001 was awarded to The Johns Hopkins University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 10, 2026.
How much is contract 75N93027C00001 worth?
The government has obligated $3,457,291 on 75N93027C00001. Its potential value, with all options, is $33,754,014.
Was contract 75N93027C00001 competed?
The extent of competition for 75N93027C00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award